| Triptorelin studied in …STUDIED_INderived63 of 63show fewer |
|---|
| → studied in | NCT02005887Phase 2 · completed TRial on the Endocrine Activity of Neoadjuvant Degarelix · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06513962Phase 3 · recruiting Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer · 63 trials list this drug (14 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066690Phase 3 · completed Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455903Phase 2 · recruiting Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04484818Phase 3 · active not recruiting Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study · 63 trials list this drug (14 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05982093Phase 2 · recruiting Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896566Phase 2 · completed A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066703Phase 3 · completed Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 63 trials list this drug (14 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667069Phase 3 · completed Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01673984Phase 4 · terminated GP Extended Action Triptorelin · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278185Phase 2 · completed Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06795191Phase 3 · withdrawn Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685397Phase 2/Phase 3 · active not recruiting Management of Castration-Resistant Prostate Cancer with Oligometastases · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06473259recruiting Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients · 63 trials list this drug (14 active) | — | — | Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899077Phase 2 · unknown Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05851547Phase 2 · recruiting Dose Escalation For INtraprostatic LEsions · 63 trials list this drug (14 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242017Phase 2/Phase 3 · recruiting Long-term Better Than Short-term ADT With Salvage RT · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727671Phase 4 · completed Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727684Phase 4 · completed Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616729Phase 1/Phase 2 · unknown DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800197unknown Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412022Phase 3 · unknown HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557604Phase 2 · recruiting Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02113553Phase 2 · terminated Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05212857Phase 2 · unknown Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112692NA · unknown Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 63 trials list this drug (14 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104741Phase 3 · completed Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00090844Phase 2 · terminated Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01753297Phase 4 · completed A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659551Phase 2 · completed Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168062Phase 2 · terminated Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer · 63 trials list this drug (14 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742675Phase 2 · unknown Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01715129Phase 3 · completed Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00444639Phase 2 · terminated Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01374087Phase 2 · terminated Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02238366completed Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01257425Phase 2 · completed Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01020448Phase 3 · completed Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00194792Phase 2 · terminated Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066807Phase 3 · terminated Premenopausal Endocrine Responsive Chemotherapy Trial · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659373Phase 3 · completed Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003734Phase 3 · unknown Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02749825Phase 4 · terminated Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160315Phase 2/Phase 3 · completed Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure · 63 trials list this drug (14 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02102646Phase 4 · completed MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01873378NA · completed GnRH Agonist Pretreatment in Hysteroscopic Myomectomy · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02022228NA · unknown Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02022241NA · unknown Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01161563Phase 4 · completed Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00311636Phase 3 · completed Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery · 63 trials list this drug (14 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01764230NA · completed Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients · 63 trials list this drug (14 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003026Phase 3 · completed Hormone Therapy in Treating Patients With Advanced Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417144Phase 4 · unknown Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients · 63 trials list this drug (14 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375687NA · unknown Investigation of Early Hormonotherapy Efficacy of Prostate Cancer · 63 trials list this drug (14 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |